New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
New Delhi [India], December 18 (ANI): Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech along with Suchitra Ella Joint Managing Director, Bharat Biotech, met Professor, Dr Tran Van Thuan, Deputy Minister of Health, Government of the Socialist Republic of Vietnam, in New Delh
New Delhi [India], December 16 (ANI): Hyderabad-based biotechnology company Bharat Biotech on Thursday announced that it will donate two lakh doses of its COVID-19 vaccine Covaxin to Vietnam.
New Delhi [India], November 30 (ANI): The Interim Phase II, III clinical trial data of COVAXIN on Healthy Volunteers aged 2 to 18 years submitted by Bharat Biotech was deliberated in the meeting of the Subject Expert Committee (SEC) on August 28 and October 11, informed Ministry of Health an
New Delhi [India], November 30 (ANI): The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in an emergency situation subject to various cond
New Delhi [India], November 25 (ANI): Commenting on the study of the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, the Hyderabad-based Bharat Biotech has said that the results compare well with 65.2 per cent efficacy against Delta variant obt
New Delhi [India], November 24 (ANI): Two doses of COVID-19 vaccine Covaxin (BBV152) are 50 per cent effective against symptomatic COVID-19 disease, according to the first real-world assessment of the COVID-19 vaccine published in the Lancet Infectious Diseases journal.
New Delhi [India], November 24 (ANI): The development of the country's indigenous COVID-19 vaccine Covaxin is a true success story for public-private partnerships in India, which is based on mutual respect, trust and transparency, said Dr Krishna Ella, Chairman and Managing Director, Bharat
New Delhi [India], November 22 (ANI): With the administration of 32,99,337 COVID-19 vaccine doses in the last 24 hours, India's COVID-19 vaccination coverage has exceeded 116.87 crore, the Union Health Ministry informed on Monday.
New Delhi [India], November 21 (ANI): Over 130 crore COVID-19 vaccine doses have been provided to states and union territories so far through free of cost channel and through direct state procurement category, said the Union Health Ministry on Sunday.
New Delhi [India], November 18 (ANI): As many as 110 countries have given recognition to the COVID-19 vaccines- Covaxin and Covishield, the official sources informed on Thursday.
Kochi (Kerala) [India], November 16 (ANI): The Kerala High Court on Tuesday asked the Central government if it is duty-bound to redress the grievance of a person who loses their livelihood due to the vaccine administered by the state.